Vaccination Warnings and Invalid Reason Descriptions

If an immunization does not meet criteria during the immunization history evaluation process, vaccination warnings and invalid reasons identify why.

The warnings indicates that the immunization is acceptable in the series and does not need to be repeated, but was perhaps given as off-label (not meeting the vaccine licensure recommendation), or at an interval earlier than the recommended minimum interval.

Immunization warnings are based on guidance from the CDC National Immunization Program and may not be documented in the ACIP Guidelines.

An immunization flagged with an invalid vaccination reason did not meet the minimum criteria for satisfying the dose in the series schedule and must be repeated.

The following table contains vaccination warning and invalid reason descriptions:

Warning Type	Description
INVALID	Antigen not recommended for primary series.
INVALID	Antigen recommended for booster dose only.
INVALID	Dose is not valid as last dose of series. Additional dose of HepB is needed.
INVALID	Hepatitis B Series 1 Non-Responsive
INVALID	Hib #3 administered >= 12 months of age requires 8 week interval from dose 2 to satisfy final dose.
INVALID	HPV bivalent vaccine is not appropriate for male vaccination or cannot be validated due to missing gender.
INVALID	Live vaccines not administered on same date must be separated by 28 days.
INVALID	Measles or Varicella containing vaccine administered < 14 days prior to antibody containing product.
INVALID	Measles or Varicella containing vaccine administered less than recommended interval following antibody containing product.
INVALID	Minimum age for this dose not met.
INVALID	Minimum interval from Dose 1 not met.
INVALID	Minimum interval from previous dose not met.
INVALID	No schedule found for antigen based on age or intervals.
INVALID	OPV bivalent and OPV monovalent are not acceptable for Polio series.
INVALID	Patient age outside of recommended schedule.
INVALID	Pediatric/adolescent vaccine recorded as administered to adult >= 19 years of age.
INVALID	Supplemental PCV dose should be administered as PCV-13 to patients less than 5 years of age.
INVALID	Supplemental Polio dose should be administered as IPV to patients less than 18 years of age.
INVALID	Tdap administered at <7 years of age and as dose 1, 2, or 3 should be repeated.
INVALID	Vaccine administered after lot number expiration date.
INVALID	Vaccine marked as Compromised.
INVALID	Vaccine not licensed in U.S.
WARNING	Antigen administered off-label but CDC dose not recommend repeating dose.
WARNING	DTaP-Hib-IPV Dose 4 administered at <4 years of age does not satisfy the IPV dose 4 minimum age. Another IPV should be administered at >= 4 years of age.
WARNING	Influenza 9+ years administered to patient under 9 years of age.
WARNING	Minimum interval from previous dose not met but CDC does not recommend repeating this dose.
WARNING	Patient may be on Twinrix alternative schedule.
WARNING	PCV13 is recommended for children ages 14-59 mos. previously complete for CPV7.
WARNING	Rotavirus Dose 1 administered at age greater than recommended age. CDC recommends completing series if patient age at time of next dose is <= 8 months of age.
WARNING	Seasonal Influenza Nasal and Novel Influ-H1N1-09 Nasal should not be administered at same visit but CDC doe snot recommend repeating the doses.
WARNING	Tdap administered at <7 years of age and dose number >3 is counted as valid for DTaP.
WARNING	The minimum recommended interval between DTaP-3 and DTaP-4 is 6 months. However, DTaP-4 need not be repeated if administered at least 4 months after DTaP-3.
WARNING	The minimum recommended interval between Td and Tdap is 5 years. However, shorter intervals may be counted as valid.
WARNING	Zoster, live should be followed by 2 doses of zoster, recombinant vaccine.
WARNING	DTaP or Ped DT administered at >= 7 years of age.
WARNING	DTaP/HepB/IPV is not approved for doses 4 or 5 of DTaP or IPV but CDC does not recommend repeating the dose.
WARNING	DTaP/Hib/IPV should not be administered as dose 5 DTaP or to children >= 5 years of age but CDC does not recommend repeating the dose.
WARNING	DTaP/IPV is not approved for doses 1 through 3 of IPV but CDC does not recommend repeating the dose.
WARNING	DTaP/IPV is not approved for doses 1 through 4 of DTaP but CDC does not recommend repeating the dose.
WARNING	HepA/HepB Adult (Twinrix) administered at < 18 years of age.
WARNING	Herpes Zoster administered to person < 50 years of age but CDC does not recommend repeating the dose.
WARNING	Influenza nasal administered to < 24 months of age. CDC does not recommend repeating the dose.
WARNING	Influenza Nasal administered to patient > 49 years of age.
WARNING	Influenza recombinant administered at < 18 years or > 49 years of age.
WARNING	Influenza, 18+ years administered at < 18 years of age.
WARNING	Influenza, 36+ months administered at < 36 months of age.
WARNING	Influenza, 48+ months administered at < 48 months of age.
WARNING	Influenza, 6-35 months administe4ed at < 6 months of age or > 35 months of age.
WARNING	PCV-13 and PPSV should be separated by one year but CDC does not recommend repeating either dose.
WARNING	Pediatric/Adolescent vaccine recorded as administered to adult >= 19 years of age.
WARNING	PPV23 administered at < 24 months of age.
WARNING	Td administered at < 7 years of age.
WARNING	Tdap administered at < 10 years of age.
WARNING	Tdap administered at > 64 years of age.
WARNING	TIV (Flu) High-Dose administered at < 65 years of age.
WARNING	Antigen not recommended for primary Hib series and CDC recommends disregarding in forecast.
WARNING	Birth HepB with Pediarix or HepB Dose 3 prior to min. interval or min. age requires four doses.
WARNING	Dose administered to patient with contraindication or adverse reaction to previous dose.
WARNING	Duplicate immunization event recorded for vaccine group.
WARNING	HepA Dose 2 following a 3-dose HepA antigen at < 18 yrs and < 6 month interval is not used in forecast. Forecast interval will be 6 months from Dose 1.
WARNING	Multiple doses administered for single dose series.
WARNING	Multiple doses administered for single dose series. Revaccination for meningococcal recommended for high risk only.
WARNING	Multiple doses Tdap. Extra Tdap dose only recommended during pregnancy.
WARNING	PCV13 is recommended for adults >= 65 years of age.
WARNING	This additional dose not required.